top of page

Emtreo 5 mg Injection

SKU Emcure Pharmaceuticals Ltd
Original price

$243.65

Sale price

$207.62

Emtreo 5 mg Injection is a powerful anticancer treatment designed to combat ovarian cancer, either on its own or in conjunction with other chemotherapy agents. This medication plays a vital role in the management of allogeneic hematopoietic stem cell transplantation for adult patients suffering from both malignant and non-malignant conditions. Additionally, Emtreo is also applicable for pediatric patients over one month old who are facing malignant diseases. However, it is essential to note that the safety and effectiveness of Emtreo Injection in infants under one month have not been established. This medication works by targeting rapidly dividing cancer cells, thereby inhibiting their growth and spread within the body. As with any chemotherapy treatment, patients should be closely monitored for potential side effects and should discuss any concerns with their healthcare provider. Emtreo offers hope in the fight against cancer, making it an essential option in modern oncology practices. Always consult a healthcare professional to ensure it is the right choice for your specific medical needs.

Quantity

Active Pharmaceutical Ingredient

Treosulfan 5 mg

Uses

• Emtreo 5 mg injection is primarily used in the management of ovarian cancer, a condition that originates in the ovaries. This treatment helps to target and inhibit the growth of cancerous cells within the reproductive system. Patients may receive Emtreo 5 mg injection as part of a comprehensive treatment plan, which may include surgery and other therapies. Its role is crucial in improving outcomes for individuals diagnosed at various stages of the disease.
• In cases where ovarian cancer is diagnosed, Emtreo 5 mg injection can assist in alleviating some of the symptoms associated with advanced stages of the condition. While early-stage ovarian cancer may present few symptoms, later stages often involve significant weight loss and loss of appetite. By addressing the cancer more effectively, Emtreo 5 mg injection may contribute to better overall health and well-being for patients. This can ultimately enhance their quality of life during treatment.
• Emtreo 5 mg injection is often utilized in conjunction with other therapeutic modalities to provide a more effective approach to treating ovarian cancer. This combination can enhance the efficacy of the overall treatment regimen and may help to reduce the risk of cancer progression. Healthcare providers may recommend Emtreo 5 mg injection based on individual patient needs and the specifics of their diagnosis. This tailored approach aims to optimize patient outcomes and improve treatment response.
• For patients experiencing recurrent ovarian cancer, Emtreo 5 mg injection serves as a valuable option in their treatment arsenal. Its mechanism of action targets the cancer cells directly, which can help to manage the disease more effectively. This injection may be part of a salvage therapy approach, particularly when other treatments have not yielded the desired results. By incorporating Emtreo 5 mg injection, clinicians can offer hope and potential for improved disease control.

Benefits

Ovarian cancer is a type of cancer that begins in the ovaries, which are the female reproductive organs that produce eggs. The symptoms of ovarian cancer may include abdominal bloating or swelling, pelvic pain or discomfort, difficulty eating or feeling full quickly, and changes in bowel or bladder habits. However, these symptoms can also be caused by other conditions, so it is important to see a healthcare provider if you are experiencing any of these symptoms. Emtreo 5 mg Injection works by damaging the DNA of cancer cells, which can slow or stop their growth.

Allogeneic hematopoietic stem cell transplantation (HSCT) is a medical procedure in which stem cells are taken from a donor and transplanted into a patient who has a disease that affects their blood cells or bone marrow. This procedure is used to treat certain types of cancers, such as leukaemia, lymphoma, and multiple myeloma, as well as some non-cancerous conditions such as severe aplastic anaemia, sickle cell disease, and thalassemia.

Side Effects

Like all medicines, this Emtreo 5 mg Injection can cause side effects, although not everybody gets them. Your doctor will discuss these with you and explain the risks and benefits of your treatment.

Most Common Side Effects

• Fatigue
• Asthenia
• Lethargy
• Blood bilirubin increased

Common Side Effects

• Infections (bacterial, viral, fungal)
• Decreased appetite
• Insomnia
• Headache
• Dizziness
• Stomatitis
• Diarrhoea
• Nausea
• Abdominal pain
• Myelosuppression
• Pancytopenia
• Pruritus

How To Use

Emtreo 5 mg Injection is administered intravenously at a hospital or clinic setting by a doctor or nurse. However, the exact treatment regimen will depend on a variety of factors, including the type and stage of the patient's cancer, their overall health, and other individual factors. The dosage and frequency of Emtreo Injection will be determined by your doctor.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Emtreo Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Emtreo Injection and report any unusual symptoms or changes in kidney function to their physician. The dose of Emtreo Injection should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not known whether Emtreo 5 mg Injection is excreted in human milk. Because many drugs, including other anthracyclines, are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Emtreo 5 mg Injection, lactating women should be advised not to breastfeed during treatment with Emtreo Injection and for at least 7 days after last dose.
• Liver: Emtreo 5 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Emtreo Injection and report any unusual symptoms or changes in liver function to their doctor. The dose of Emtreo Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Emtreo 5 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Emtreo Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Emtreo 5 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Emtreo Injection.

bottom of page